Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-21 | New | $99,269,270 | $99,269,270 | Equity Only | 06b | SEC link |
| 2024-06-06 | Amended | $38,383,040 | $8,524,997 | Equity Only | 06b | SEC link |
| 2024-05-07 | Amended | $29,858,043 | $2,983,052 | Equity Only | 06b | SEC link |
| 2024-04-25 | New | $26,874,991 | $26,874,991 | Equity Only | 06b | SEC link |
| 2023-10-12 | New | $103,230,763 | $103,230,763 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jishnu Bhattacharjee | Director |
| Neil Josephson | Executive |
| Fred Manby | Director, Executive |
| Thomas Miller | Director, Executive |
| Pete Olson | Executive |
| Evan Rachlin | Director |
| William Rastetter | Director |
| Michael Secora | Executive |
| Shalini Sharp | Director |
| Mary Tagliaferri | Director |
| Tabbert Teng | Executive |
| R. Jacob Vogelstein | Director |
| Kurt Von Emster | Director |
| Chao Zhang | Executive |